Bibliography
Found 105 results
Filters: Keyword is HIV-1 [Clear All Filters]
Human immunodeficiency virus and the central nervous system. The Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases [Internet]. 2006 ;10:41-50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16767315
. Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology [Internet]. 2007 ;27:86-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17226745
. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy. J Infect Dis. 2017 ;215(1):105-113.
Better executive function is independently associated with full HIV suppression during combination therapy. AIDS. 2019 ;33(15):2309-2316.
. Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience [Internet]. 2006 ;26:4054-62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16611822
. Phenotypic Correlates of HIV-1 Macrophage Tropism. J Virol. 2015 ;89(22):11294-311.
The neurotrophin receptor p75 mediates gp120-induced loss of synaptic spines in aging mice. Neurobiol Aging. 2016 ;46:160-8.
. Blood-brain barrier pericytes as a target for HIV-1 infection. Brain. 2019 ;142(3):502-511.
. HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1. J Immunol. 2011 ;186(7):4119-29.
. HIV-1 Tat promotes astrocytic release of CCL2 through MMP/PAR-1 signaling. Glia. 2019 ;67(9):1719-1729.
. Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection. J Neuroimmune Pharmacol. 2016 ;11(2):279-93.
. HIV Infection Induces Extracellular Cathepsin B Uptake and Damage to Neurons. Sci Rep. 2019 ;9(1):8006.
. Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis. AIDS. 2015 ;29(16):2081-92.
. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood [Internet]. 2008 ;111:2062-72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18003888
. Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology [Internet]. 2007 ;21:777-89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17197385
. Cellular immunology in HIV-1 positive African American women using alcohol and cocaine. Frontiers in Bioscience: A Journal and Virtual Library [Internet]. 2006 ;11:2434-41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16720325
. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 ;18(2):81-90.
Human immunodeficiency virus infection inhibits granulocyte-macrophage colony-stimulating factor-induced microglial proliferation. Journal of Neurovirology [Internet]. 2007 ;13:536-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18097885
. CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis. Brain Pathology (Zurich, Switzerland) [Internet]. 2006 ;16(4):256-65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17107594
. Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrob Agents Chemother. 2012 ;56(4):1985-9.
Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence. PLoS One. 2014 ;9(7):e102555.
. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology. 2013 ;80(15):1415-23.
. Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women. Frontiers in Bioscience: A Journal and Virtual Library [Internet]. 2007 ;12:1488-95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17127396
. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment. PLoS One. 2016 ;11(6):e0157160.